Skip to main content

MoneyWorks4Me

Ajanta Pharma informs about board meeting

15 Oct 2026 Evaluate
Ajanta Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 30/10/2026 to consider and approve Unaudited consolidated and standalone financial results of the Company for the second quarter and half year ended 30th September 2026.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1875.00
Dr. Reddys Labs. 1371.85
Cipla 1394.60
Lupin 1981.60
Zydus Lifesciences 1200.55
View more..